Año: 2013
Journal Impact Factor (JIF): 2.3310
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CHEMISTRY, ORGANIC | SCIE | 25/58 | Q2 | T2 | D5 |
CHEMISTRY, MEDICINAL | SCIE | 32/58 | Q3 | T2 | D6 |
Año: 2017
Journal Citation Indicator (JCI): 0,910
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CHEMISTRY, MEDICINAL | 24/70 | Q2 | T2 | D4 | 66,43 |
CHEMISTRY, ORGANIC | 15/62 | Q1 | T1 | D3 | 76,61 |
Año:
2013
CiteScore:
4,600
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmaceutical Science | 29/179 | Q1 | T1 | D2 |
Drug Discovery | 44/147 | Q2 | T1 | D3 |
General Medicine | 911/3233 | Q2 | T1 | D3 |
Organic Chemistry | 41/161 | Q2 | T1 | D3 |
Biochemistry | 140/371 | Q2 | T2 | D4 |
Clinical Biochemistry | 46/119 | Q2 | T2 | D4 |
Molecular Medicine | 72/149 | Q2 | T2 | D5 |
Molecular Biology | 178/347 | Q3 | T2 | D6 |
SJR año:
2013
Factor de Impacto:
0,931
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmaceutical Science | 32/220 | Q1 | T1 | D2 |
Drug Discovery | 52/184 | Q2 | T1 | D3 |
Organic Chemistry | 53/175 | Q2 | T1 | D4 |
Clinical Biochemistry | 49/131 | Q2 | T2 | D4 |
Biochemistry | 175/415 | Q2 | T2 | D5 |
Molecular Biology | 226/387 | Q3 | T2 | D6 |
Molecular Medicine | 91/172 | Q3 | T2 | D6 |
Agencia | Código de Proyecto |
---|---|
CSIC | - |
Generalitat de Catalunya | 2009/SGR/208 |
Juan de la Cierva contract (MICINN, Spain) | - |
Ministry of Education, Culture and Sports | - |
Spanish Ministry of Economy and Competitiveness | CTQ2009-13705; CTQ2010-20541 |
# | Autor | Afiliación |
---|---|---|
1 | Vengut-Climent, Empar | Universidad de Sevilla (Spain) |
2 | Terrazas, Montserrat | CIBER Bioingenieria, Biomateriales y Nanomedicina (Spain) |
3 | Lucas, Ricardo | Universidad de Sevilla (Spain) |
4 | Arévalo-Ruiz, Matilde | Universidad de Sevilla (Spain) |
5 | Eritja, Ramón | CIBER Bioingenieria, Biomateriales y Nanomedicina (Spain) |
6 | Universidad de Sevilla (Spain) |